GENETIC AND ANTIGENIC VARIABILITY OF HIV TYPE-1 IN BRAZIL

被引:19
作者
COUTOFERNANDEZ, JC
JANSSENS, W
HEYNDRICKX, L
MOTTE, J
FRANSEN, K
PEETERS, M
DELAPORTE, E
GALVAOCASTRO, B
PIOT, P
VANDERGROEN, G
机构
[1] INST TROP MED,DEPT INFECT & IMMUN,DIV MICROBIOL,B-2000 ANTWERP,BELGIUM
[2] FDN OSWALDO CRUZ,CTR PESQUISAS GONCALO,ADV PUBL HLTH LAB,BR-41945 SALVADOR,BRAZIL
[3] HOP BICHAT CLAUDE BERNARD,IMEA,INSERM,U13,PARIS,FRANCE
关键词
D O I
10.1089/aid.1994.10.1157
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Six Brazilian strains of human immunodeficiency virus type 1 (HIV-1) were isolated from infected individuals residing in different regions of Brazil between 1987 and 1989. Phylogenetic analysis based on an 860-base pair env fragment, including V3, V4, V5, and the beginning of gp41, classified the Brazilian strains significantly in genotype B, with interhost distances between 5.9 and 13.1% (mean value, 10%). Amino acid sequence analysis of the V3 loop revealed that three strains contained the North American/European GPGR moth as the tip of the loop whereas in the other three strains proline (P) was substituted by tryptophan (W), methionine (M), or phenylalanine (F). A consensus peptide, Bra-cons, was designed containing GWGR as the tip of the loop. Serological reactivity to the Bra-cans peptide and other V3 peptides (MN, SF2, HBX2, RF, MAL, ELI, Z6, and a Cote d'Ivoire peptide, CI-cons) was compared for 114 HIV-1-positive sera from Rio de Janeiro. Sixty-nine sera (60.5%) reacted with peptides belonging to genotype B, of which 10 sera also reacted with peptides belonging to genotype A (n = 7) and D (n = 3). Eighteen sera (15.8%) had binding antibodies to the Bra-cons peptide. A high number of sera (n = 43; 37.7%) had no antibodies to any of the V3 peptides tested. This result suggests that HIV-1 variants with aberrant V3 loops may circulate in Rio de Janeiro.
引用
收藏
页码:1157 / 1163
页数:7
相关论文
共 33 条
[1]   HIV REVEALED - TOWARD A NATURAL-HISTORY OF THE INFECTION [J].
BALTIMORE, D ;
FEINBERG, MB .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1673-1675
[2]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[3]  
CARRILLO MG, 1992, REV ARG MICROBIOL, V24, P91
[4]   IMPACT OF THE 1993 REVISION OF THE AIDS CASE-DEFINITION ON THE PREVALENCE OF AIDS IN A CLINICAL SETTING [J].
CHAISSON, RE ;
STANTON, DL ;
GALLANT, JE ;
RUCKER, S ;
BARTLETT, JG ;
MOORE, RD .
AIDS, 1993, 7 (06) :857-862
[5]  
COUTOFERNANDEZ JC, 1993, MEM I O CRUZ, V87, P249
[6]   DIRECT SOLID-PHASE SEQUENCING OF GENOMIC AND PLASMID DNA USING MAGNETIC BEADS AS SOLID SUPPORT [J].
HULTMAN, T ;
STAHL, S ;
HORNES, E ;
UHLEN, M .
NUCLEIC ACIDS RESEARCH, 1989, 17 (13) :4937-4946
[7]   IDENTIFICATION OF THE ENVELOPE V3 LOOP AS THE PRIMARY DETERMINANT OF CELL TROPISM IN HIV-1 [J].
HWANG, SS ;
BOYLE, TJ ;
LYERLY, HK ;
CULLEN, BR .
SCIENCE, 1991, 253 (5015) :71-74
[8]   V3 LOOP REGION OF THE HIV-1 GP120 ENVELOPE PROTEIN IS ESSENTIAL FOR VIRUS INFECTIVITY [J].
IVANOFF, LA ;
DUBAY, JW ;
MORRIS, JF ;
ROBERTS, SJ ;
GUTSHALL, L ;
STERNBERG, EJ ;
HUNTER, E ;
MATTHEWS, TJ ;
PETTEWAY, SR .
VIROLOGY, 1992, 187 (02) :423-432
[9]   MOLECULAR PHYLOGENY OF PART OF THE ENV GENE OF HIV-1 STRAINS ISOLATED IN COTE-DIVOIRE [J].
JANSSENS, W ;
HEYNDRICKX, L ;
VANDEPEER, Y ;
BOUCKAERT, A ;
FRANSEN, K ;
MOTTE, J ;
GERSHYDAMET, GM ;
PEETERS, M ;
PIOT, P ;
VANDERGROEN, G .
AIDS, 1994, 8 (01) :21-26
[10]   PRINCIPAL NEUTRALIZING DOMAIN OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ENVELOPE PROTEIN [J].
JAVAHERIAN, K ;
LANGLOIS, AJ ;
MCDANAL, C ;
ROSS, KL ;
ECKLER, LI ;
JELLIS, CL ;
PROFY, AT ;
RUSCHE, JR ;
BOLOGNESI, DP ;
PUTNEY, SD ;
MATTHEWS, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6768-6772